Results 141 to 150 of about 5,803 (182)

Hepatitis C virus in childhood and pregnancy. [PDF]

Infect Dis Immun
Reed JC, Chung RT.
europepmc   +1 more source

Trends in Use of Direct-Acting Antivirals for Treatment of Hepatitis C Virus Infection in Australia 2016-2024. [PDF]

J Viral Hepat
Luong CL, Ellett LK, Pratt N, Staff K, Janetzki J.   +4 more
europepmc   +1 more source

A case report of sofosbuvir induced drug eruption and literature review. [PDF]

IDCases
Xia A, Liu J, Tang C, Xu H.
europepmc   +1 more source

Medicaid and Medicare Utilization of Direct-Acting Antiviral Medications for Patients With Hepatitis C. [PDF]

Gastro Hep Adv
Ying X, Zhao A, Ng N, Rosenblatt R, Lucero C, Jesudian AB.   +5 more
europepmc   +1 more source

Epidemiological characteristics, genotype patterns, and treatment outcomes in chronic hepatitis C patients receiving direct-acting antivirals: a cohort study from Istanbul, Türkiye. [PDF]

BMC Infect Dis
Karaman Kamalı S, Senoglu S, Kamalı S, Ozdemir YE, Kart Yasar K.   +4 more
europepmc   +1 more source

Prevalence of resistance-associated substitutions (RAS) in hepatitis C virus in the Former Soviet Union countries. [PDF]

BMJ Open Gastroenterol
Mustafa A, Davlidova S, Abidi SH, Begimbetova D, Heimer R, Vermund SH, Ali S.   +6 more
europepmc   +1 more source

Modeling predicts shortening of DAA treatment duration to 5 weeks in individuals with recent or chronic infection with HCV RNA negativity at day 7 on treatment. [PDF]

J Infect Dis
Goyal A, Cotler SJ, Matthews GV, Page K, Kushner T, Etzion O, Martinello M, Dahari H.   +7 more
europepmc   +1 more source

Treatment with Direct-Acting Antivirals in Patients with HCV Infection After Liver Transplantation. [PDF]

J Clin Med
Brzdęk M, Zarębska-Michaluk D, Tronina O, Laurans Ł, Janczewska E, Dybowska D, Parfieniuk-Kowerda A, Tudrujek-Zdunek M, Białkowska-Warzecha J, Janocha-Litwin J, Flisiak R.   +10 more
europepmc   +1 more source

Evidence Supporting Utility of the Oral Cholate Challenge Test of Liver Function and Physiology to Aid Clinical Management: A Review of Analytical and Clinical Validation Studies. [PDF]

Gastro Hep Adv
Keaveny AP, Qureshi K, Shiffman M, Morgan TR, Reddy KR, Imperial JC, McRae MP, Shokati T, Everson GT.   +8 more
europepmc   +1 more source

<i>RhoJ</i> promotes the progression of clear cell renal cell carcinoma via the TNF-α/NF-κB axis. [PDF]

Transl Androl Urol
Feng J, Zheng B, Wang J, Xu Q, Ouyang Q, Li H, Jia T, Wang Y, Cai T, Feng Y, Zhang X, Li X, Ma X.   +12 more
europepmc   +1 more source